The diagnosis of Alzheimer’s disease requires careful analysis of the signs and symptoms of the individual with cognitive decline.1 The available clinical scales can measure general cognitive abilities, comparing scores against those of an average person in the same age group and demographics as the individual with subjective cognitive decline.1 With this, healthcare professionals can confirm the presence of cognitive and functional decline.1

file_download Download in HQ

Related content

image Image A multi-arm, multi-stage platform trial illustration
A multi-arm, multi-stage platform trial illustration
29.04.2025 Alzheimer’s Disease
image Image Drug Delivery Systems to the Brain
Drug Delivery Systems to the Brain

Brain drug delivery systems, allied with their characteristics for overcoming the blood-brain barrier (BBB).

29.04.2025 Alzheimer’s Disease
image Image From One-Size-Fits-All to Precision Medicine
From One-Size-Fits-All to Precision Medicine

The use of a single treatment in heterogeneous populations has proved problematic in clinical trials undertaken in patients with neurodegenerative diseases.

29.04.2025 Alzheimer’s Disease